Methoxsalen

4 trials 2 recruiting LOncology Orphan designation

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

3 Sponsors

6 Countries

Phase II

Phase I/II

Phase II: 3 Phase I/II: 1

Indications tested

Acute graft versus host disease 1 Chronic graft versus host disease 1 Adverse drug reaction 1

Sponsors using this IMP

Medical Center - University Of Freiburg 2 CHRU De Nancy 1 Medac Gesellschaft fuer klinische Spezialprapaerate mbH 1

All trials

4 total

Phase 2 Trial to determine the safety and efficacy of simultaneous treatment with ruxolitinib and extracorporeal photopheresis for patients … Recruiting

2023-507754-33-00 Phase II 2 countries Medical Center - University Of Freiburg
A multi-center randomized phase II study comparing corticosteroids alone versus corticosteroids and extracorporeal photopheresis as first-li… Recruiting

2023-508614-41-00 Phase II 1 country CHRU De Nancy
Trial of efficacy and safety of MC0518 versus best available therapy in patients with steroid-refractory acute graft versus host disease Ended

2023-503952-28-00 Phase II 5 countries Medac Gesellschaft fuer klinische Spezialprapaerate mbH
Extracorporeal photopheresis as treatment for immune related adverse events after immunotherapy Ended

2024-513614-36-00 Phase I/II 1 country Medical Center - University Of Freiburg

Showing 1–4 of 4 trials

← All drugs A–Z